Des Jardin Michael A. Insider Trades

Insider Trading History

Track insider trading activity for Des Jardin Michael A.. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Horizon Therapeutics Plc
Horizon Therapeutics Plc HZNP
Evp, Technical Operations
Holding Value $14.6M 125,815 shares
Last Trade
Mar 02, 2023 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$400k 3,629 shares
$110.25
$116.30
Horizon Therapeutics Plc
Horizon Therapeutics Plc HZNP
Evp, Technical Operations
Holding Value $0 0 shares
Last Trade
Mar 02, 2023 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$400k 3,629 shares
$110.25
$116.30
Horizon Therapeutics Plc
Horizon Therapeutics Plc HZNP
Evp, Technical Operations
Holding Value $14.7M 126,558 shares
Last Trade
Mar 02, 2023 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$81.9k 743 shares
$110.25
$116.30
Horizon Therapeutics Plc
Horizon Therapeutics Plc HZNP
Evp, Technical Operations
Holding Value $0 0 shares
Last Trade
Mar 02, 2023 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$81.9k 743 shares
$110.25
$116.30
Horizon Therapeutics Plc
Horizon Therapeutics Plc HZNP
Evp, Technical Operations
Holding Value $1.66M 14,283 shares
Last Trade
Jan 05, 2023 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$809k 7,141 shares
$113.24
$116.30
Horizon Therapeutics Plc
Horizon Therapeutics Plc HZNP
Evp, Technical Operations
Holding Value $1.22M 10,479 shares
Last Trade
Jan 05, 2023 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.19M 10,478 shares
$113.24
$116.30
Horizon Therapeutics Plc
Horizon Therapeutics Plc HZNP
Evp, Technical Operations
Holding Value $14.2M 122,186 shares
Last Trade
Jan 05, 2023 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$3.05M 26,901 shares
$113.24
$116.30
Horizon Therapeutics Plc
Horizon Therapeutics Plc HZNP
Evp, Technical Operations
Holding Value $17.3M 149,087 shares
Last Trade
Jan 05, 2023 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$6.14M 54,253 shares
$113.24
$116.30
Horizon Therapeutics Plc
Horizon Therapeutics Plc HZNP
Evp, Technical Operations
Holding Value $0 0 shares
Last Trade
Jan 05, 2023 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$547k 4,834 shares
$113.24
$116.30
Horizon Therapeutics Plc
Horizon Therapeutics Plc HZNP
Evp, Technical Operations
Holding Value $609k 5,236 shares
Last Trade
Jan 05, 2023 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.19M 10,482 shares
$113.24
$116.30
Horizon Therapeutics Plc
Horizon Therapeutics Plc HZNP
Evp, Technical Operations
Holding Value $2.41M 20,697 shares
Last Trade
Jan 04, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.35M 20,697 shares
$113.48
$116.30
Horizon Therapeutics Plc
Horizon Therapeutics Plc HZNP
Evp, Technical Operations
Holding Value $11M 94,834 shares
Last Trade
Jan 01, 2023 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$1.09M 9,561 shares
$113.80
$116.30
Horizon Therapeutics Plc
Horizon Therapeutics Plc HZNP
Evp, Technical Operations
Holding Value $0 0 shares
Last Trade
Jan 01, 2023 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$2.48M 21,772 shares
$113.80
$116.30
Horizon Therapeutics Plc
Horizon Therapeutics Plc HZNP
Evp, Technical Operations
Holding Value $12.1M 104,395 shares
Last Trade
Jan 01, 2023 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$2.48M 21,772 shares
$113.80
$116.30
Horizon Therapeutics Plc
Horizon Therapeutics Plc HZNP
Evp, Technical Operations
Holding Value $2.53M 21,772 shares
Last Trade
Dec 27, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.47M 21,772 shares
$113.26
$116.30
Horizon Therapeutics Plc
Horizon Therapeutics Plc HZNP
Evp, Technical Operations
Holding Value $1.83M 15,718 shares
Last Trade
Dec 27, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.78M 15,718 shares
$113.26
$116.30
Horizon Therapeutics Plc
Horizon Therapeutics Plc HZNP
Evp, Technical Operations
Holding Value $9.61M 82,623 shares
Last Trade
Jun 01, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$24.8k 277 shares
$89.49
$116.30
Horizon Therapeutics Plc
Horizon Therapeutics Plc HZNP
Evp, Technical Operations
Holding Value $10.9M 93,410 shares
Last Trade
Apr 12, 2022 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.03M 9,150 shares
$112.55
$116.30
Horizon Therapeutics Plc
Horizon Therapeutics Plc HZNP
Evp, Technical Operations
Holding Value $9.58M 82,346 shares
Last Trade
Apr 12, 2022 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.26M 11,064 shares
$113.60
$116.30
Horizon Therapeutics Plc
Horizon Therapeutics Plc HZNP
Evp, Technical Operations
Holding Value $13.5M 116,078 shares
Last Trade
Mar 02, 2022 Sale (Open Market)Shares sold on the open market or in a private sale.
$2.08M 21,482 shares
$97.05
$116.30

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up